News

A man-made antibody successfully prevented organ rejection when tested in primates that had undergone a kidney transplant, Duke Health researchers report.

Of over 100,000 drug overdose deaths reported in the United States in 2021, 71,000 can be attributed to synthetic opioids like fentanyl. Researchers are now getting closer to human trials for vaccines to prevent fentanyl and heroin drug overdoses.

Osaka Metropolitan University scientists demonstrate the anti-cancer properties of Kencur ginger are caused by its bioactive compound, ethyl p-methoxycinnamate (EMC). In mice, this compound reduced cancer cell proliferation at low doses.

A new study in mice has shown that phytosterol, a common dietary supplement, may help to reduce age-related hearing loss.

An innovative genome-editing technique could enhance the delivery, specificity and targeting of gene-modifying tools for treatments. The KAUST-developed method combines two molecular technologies.

The FDA has approved the first vaccine against respiratory syncytial virus (RSV), designed for use during pregnancy to protect infants from severe RSV-associated respiratory disease in their first six months of life.

Getting a COVID-19 vaccine may not only reduce a person's risk of getting long-haul COVID, but also could mean fewer symptoms for people who develop the condition.

Bartter syndrome type 3 is the result of several structural variants in the genome. By using long-read sequencing, researchers mapped out the rare disease in unprecedented detail.

A new study is the first to demonstrate the ability for gene therapy to repair neural connections for those with the rare genetic brain disorder known as Hurler syndrome

The widely-used anticoagulant heparin can have potentially fatal side effects, so researchers have developed a new DNA-based drug to target blood clots.